• Samoh Pharm disclosed a change in its ownership of Aminologics securities, with total holdings slipping to 36,787,758 units on Sept. 30, 2026.
• Stake based on specific securities fell to 37.03% from 39.40% in the prior filing dated Sept. 10, 2025.
• Common shareholding stayed at 26,783,244 shares, though the common-stock stake edged down to 29.98% from 30.39%.
• Convertible bond holdings rose to 10,004,514 from 4,779,860, reflecting a call option exercise tied to the 4th convertible bond.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aminologics Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261001000613), on October 02, 2026, and is solely responsible for the information contained therein.